
Chinese General Practice ›› 2026, Vol. 29 ›› Issue (10): 1324-1333.DOI: 10.12114/j.issn.1007-9572.2024.0495
• Article • Previous Articles Next Articles
Received:2025-04-10
Revised:2026-01-24
Published:2026-04-05
Online:2026-03-25
Contact:
ZHOU Hanni
通讯作者:
周涵妮
作者简介:作者贡献:
胡嘉琦负责统筹项目研究,撰写论文初稿并负责最终版本修订,对论文负责;李端提出研究思路,设计研究方案,负责文章的质量控制与审查,对文章整体负责,为研究课题提供资金支持;方昊、李端负责数据收集,以及数据整理与统计学分析;樊兴颖、杜薇、周涵妮负责数据校验,论文修订及论文质量把控。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0495
| 项目 | 患病组 | 未患病组 | t值 | P值 |
|---|---|---|---|---|
| 年龄( | 58.6±13.8 | 55.6±15.8 | -11.354 | 0.001 |
| BMI( | 26.7±3.76 | 24.2±3.22 | -3.443 | <0.001 |
| UA( | 432.98±121.88 | 327.17±117.58 | -27.828 | <0.001 |
| TP( | 68.51±12.96 | 64.71±11.49 | -3.785 | <0.001 |
| Scr( | 121.06±33.23 | 102.44±23.33 | -8.523 | <0.001 |
| TC( | 260.57±106.83 | 185.65±89.52 | -13.523 | <0.001 |
| LDL-C( | 116.31±24.42 | 110.12±15.22 | -10.341 | <0.001 |
| TG( | 10.57±106.83 | 5.65±89.52 | -3.523 | <0.001 |
| BUN( | 21.43±12.16 | 18.13±22.12 | -1.324 | <0.001 |
| eGFR[ | 91.18±18.49 | 92.32±18.76 | 1.421 | 0.074 |
| SBP( | 139±18 | 134±18 | -2.152 | 0.001 |
| DBP( | 76±12 | 74±11 | -2.147 | 0.002 |
Table 1 Comparison of data between HUA cases and non-cases in the physical examination cohort
| 项目 | 患病组 | 未患病组 | t值 | P值 |
|---|---|---|---|---|
| 年龄( | 58.6±13.8 | 55.6±15.8 | -11.354 | 0.001 |
| BMI( | 26.7±3.76 | 24.2±3.22 | -3.443 | <0.001 |
| UA( | 432.98±121.88 | 327.17±117.58 | -27.828 | <0.001 |
| TP( | 68.51±12.96 | 64.71±11.49 | -3.785 | <0.001 |
| Scr( | 121.06±33.23 | 102.44±23.33 | -8.523 | <0.001 |
| TC( | 260.57±106.83 | 185.65±89.52 | -13.523 | <0.001 |
| LDL-C( | 116.31±24.42 | 110.12±15.22 | -10.341 | <0.001 |
| TG( | 10.57±106.83 | 5.65±89.52 | -3.523 | <0.001 |
| BUN( | 21.43±12.16 | 18.13±22.12 | -1.324 | <0.001 |
| eGFR[ | 91.18±18.49 | 92.32±18.76 | 1.421 | 0.074 |
| SBP( | 139±18 | 134±18 | -2.152 | 0.001 |
| DBP( | 76±12 | 74±11 | -2.147 | 0.002 |
| 自变量 | 赋值 |
|---|---|
| 性别 | 女=0,男=1 |
| 年龄 | ≤59岁=0,≥60岁=1 |
| 肥胖 | 否=0,是=1 |
| 婚姻情况 | 未婚=0,已婚=1,离异、丧偶=2 |
| 户籍所在地 | 农村=0,城镇=1 |
| 高血压 | 阴性=0,阳性=1 |
| 高甘油三酯血症 | 阴性=0,阳性=1 |
| 高胆固醇血症 | 阴性=0,阳性=1 |
| 低密度脂蛋白血症 | 阴性=0,阳性=1 |
Table 2 Multilevel Cox regression analysis variable assignment of influencing factors for HUA
| 自变量 | 赋值 |
|---|---|
| 性别 | 女=0,男=1 |
| 年龄 | ≤59岁=0,≥60岁=1 |
| 肥胖 | 否=0,是=1 |
| 婚姻情况 | 未婚=0,已婚=1,离异、丧偶=2 |
| 户籍所在地 | 农村=0,城镇=1 |
| 高血压 | 阴性=0,阳性=1 |
| 高甘油三酯血症 | 阴性=0,阳性=1 |
| 高胆固醇血症 | 阴性=0,阳性=1 |
| 低密度脂蛋白血症 | 阴性=0,阳性=1 |
| 组别 | 模型1 | 模型2 | 模型3 | |||
|---|---|---|---|---|---|---|
| HR(95%CI) | P值 | HR(95%CI) | P值 | HR(95%CI) | P值 | |
| 高血压 | 1.26(0.93~1.71) | 0.017 | 1.23(0.91~1.68) | 0.016 | 1.31(0.96~1.78) | 0.003 |
| 高甘油三酯血症 | 1.36(1.06~1.76) | <0.001 | 1.44(1.12~1.85) | 0.005 | 1.81(1.40~2.34) | <0.001 |
| 高胆固醇血症 | 1.73(1.34~2.25) | 0.012 | 1.74(1.35~2.25) | <0.001 | 1.40(1.09~1.81) | 0.004 |
| 高低密度脂蛋白血症 | 1.44(1.12~2.31) | 0.024 | 1.15(0.67~1.98) | 0.113 | 1.64(1.31~2.11) | 0.071 |
| 性别 | 1.25(0.94~1.65) | 0.002 | 1.00(0.88~1.10) | 0.002 | ||
| 年龄 | 1.39(1.10~1.76) | 0.001 | 1.35(1.58~1.80) | 0.002 | ||
| 肥胖 | 1.14(0.63~1.93) | 0.003 | ||||
| 婚姻情况 | 1.44(1.09~1.80) | 0.085 | ||||
| 户籍所在地 | 1.54(1.22~1.91) | 0.057 | ||||
Table 3 Multilevel Cox regression analysis of influencing factors for HUA
| 组别 | 模型1 | 模型2 | 模型3 | |||
|---|---|---|---|---|---|---|
| HR(95%CI) | P值 | HR(95%CI) | P值 | HR(95%CI) | P值 | |
| 高血压 | 1.26(0.93~1.71) | 0.017 | 1.23(0.91~1.68) | 0.016 | 1.31(0.96~1.78) | 0.003 |
| 高甘油三酯血症 | 1.36(1.06~1.76) | <0.001 | 1.44(1.12~1.85) | 0.005 | 1.81(1.40~2.34) | <0.001 |
| 高胆固醇血症 | 1.73(1.34~2.25) | 0.012 | 1.74(1.35~2.25) | <0.001 | 1.40(1.09~1.81) | 0.004 |
| 高低密度脂蛋白血症 | 1.44(1.12~2.31) | 0.024 | 1.15(0.67~1.98) | 0.113 | 1.64(1.31~2.11) | 0.071 |
| 性别 | 1.25(0.94~1.65) | 0.002 | 1.00(0.88~1.10) | 0.002 | ||
| 年龄 | 1.39(1.10~1.76) | 0.001 | 1.35(1.58~1.80) | 0.002 | ||
| 肥胖 | 1.14(0.63~1.93) | 0.003 | ||||
| 婚姻情况 | 1.44(1.09~1.80) | 0.085 | ||||
| 户籍所在地 | 1.54(1.22~1.91) | 0.057 | ||||
| 变量 | OR(95%CI) | P值 | Pe(%) | PAR(%) |
|---|---|---|---|---|
| 性别 | 1.02(1.01~1.02) | 0.024 | 65.4 | 28.3 |
| 肥胖 | 1.12(1.02~1.42) | 0.015 | 48.8 | 31.4 |
| 年龄 | 1.35(1.07~1.71) | 0.011 | 49.3 | 27.6 |
| 高血压 | 1.31(1.07~1.69) | 0.003 | 23.8 | 12.2 |
| 高甘油三酯血症 | 1.81(1.40~2.34) | <0.001 | 35.4 | 33.7 |
| 高胆固醇血症 | 1.40(1.09~1.81) | 0.009 | 41.7 | 39.4 |
Table 4 HUA attribution degree calculation
| 变量 | OR(95%CI) | P值 | Pe(%) | PAR(%) |
|---|---|---|---|---|
| 性别 | 1.02(1.01~1.02) | 0.024 | 65.4 | 28.3 |
| 肥胖 | 1.12(1.02~1.42) | 0.015 | 48.8 | 31.4 |
| 年龄 | 1.35(1.07~1.71) | 0.011 | 49.3 | 27.6 |
| 高血压 | 1.31(1.07~1.69) | 0.003 | 23.8 | 12.2 |
| 高甘油三酯血症 | 1.81(1.40~2.34) | <0.001 | 35.4 | 33.7 |
| 高胆固醇血症 | 1.40(1.09~1.81) | 0.009 | 41.7 | 39.4 |
| 编号 | 变量 | OR(95%CI) | P值 | lnOR(β) |
|---|---|---|---|---|
| 1 | 性别 | 2.61(1.79~3.81) | <0.001 | 0.959 |
| 2 | 年龄 | 1.51(1.33~2.78) | 0.002 | 0.672 |
| 3 | 肥胖 | 5.28(1.71~8.13) | 0.001 | 1.441 |
| 4 | 高血压 | 10.84(6.92~16.10) | <0.001 | 2.383 |
| 5 | 高甘油三酯血症 | 18.04(12.56~25.91) | <0.001 | 2.892 |
| 6 | 高胆固醇血症 | 4.58(3.19~6.57) | <0.001 | 1.521 |
Table 5 Screening results of non-genetic risk factors for HUA
| 编号 | 变量 | OR(95%CI) | P值 | lnOR(β) |
|---|---|---|---|---|
| 1 | 性别 | 2.61(1.79~3.81) | <0.001 | 0.959 |
| 2 | 年龄 | 1.51(1.33~2.78) | 0.002 | 0.672 |
| 3 | 肥胖 | 5.28(1.71~8.13) | 0.001 | 1.441 |
| 4 | 高血压 | 10.84(6.92~16.10) | <0.001 | 2.383 |
| 5 | 高甘油三酯血症 | 18.04(12.56~25.91) | <0.001 | 2.892 |
| 6 | 高胆固醇血症 | 4.58(3.19~6.57) | <0.001 | 1.521 |
| NGRS组合 | 纳入候选非遗传因素编号 |
|---|---|
| HUANGRS3 | 3,4,6 |
| HUANGRS4 | 3,4,6,1 |
| HUANGRS5 | 3,4,6,1,5 |
| HUANGRS6 | 3,4,6,1,5,2 |
Table 6 Combination of different non-genetic factors in HUA
| NGRS组合 | 纳入候选非遗传因素编号 |
|---|---|
| HUANGRS3 | 3,4,6 |
| HUANGRS4 | 3,4,6,1 |
| HUANGRS5 | 3,4,6,1,5 |
| HUANGRS6 | 3,4,6,1,5,2 |
| NGRS组合 | 总体人群 | 非老年人 | 老年人 | |||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| HUANGRS3 | 1.45(1.20~2.31) | 0.005 | 1.70(1.55~5.36) | 0.008 | 1.56(1.26~4.42) | 0.018 |
| HUANGRS4 | 1.27(0.88~1.81) | <0.001 | 1.73(1.58~5.94) | 0.003 | 1.66(1.36~4.97) | 0.007 |
| HUANGRS5 | 1.39(1.17~2.16) | 0.005 | 1.44(1.19~2.26) | 0.006 | 1.51(1.22~3.82) | 0.005 |
| HUANGRS6 | 1.36(1.13~2.11) | 0.025 | 1.53(1.24~4.11) | 0.010 | 1.24(0.79~1.69) | 0.011 |
Table 7 Logistic regression analysis of different NGRS with HUA in total population, non-elderly and elderly
| NGRS组合 | 总体人群 | 非老年人 | 老年人 | |||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| HUANGRS3 | 1.45(1.20~2.31) | 0.005 | 1.70(1.55~5.36) | 0.008 | 1.56(1.26~4.42) | 0.018 |
| HUANGRS4 | 1.27(0.88~1.81) | <0.001 | 1.73(1.58~5.94) | 0.003 | 1.66(1.36~4.97) | 0.007 |
| HUANGRS5 | 1.39(1.17~2.16) | 0.005 | 1.44(1.19~2.26) | 0.006 | 1.51(1.22~3.82) | 0.005 |
| HUANGRS6 | 1.36(1.13~2.11) | 0.025 | 1.53(1.24~4.11) | 0.010 | 1.24(0.79~1.69) | 0.011 |
| NGRS组合 | 总体人群 | 非老年人 | 老年人 | |||
|---|---|---|---|---|---|---|
| AUC(95%CI) | P值 | AUC(95%CI) | P值 | AUC(95%CI) | P值 | |
| HUANGRS3 | 0.76(0.61~0.82) | <0.001 | 0.72(0.59~0.81) | <0.001 | 0.79(0.66~0.86) | <0.001 |
| HUANGRS4 | 0.68(0.56~0.75) | <0.001 | 0.78(0.63~0.83) | 0.001 | 0.82(0.74~0.88) | <0.001 |
| HUANGRS5 | 0.82(0.73~0.87) | <0.001 | 0.81(0.73~0.87) | <0.001 | 0.77(0.63~0.83) | <0.001 |
| HUANGRS6 | 0.67(0.53~0.73) | <0.001 | 0.75(0.61~0.81) | 0.001 | 0.79(0.64~0.85) | 0.001 |
Table 8 Comparison of prediction effectiveness of different NGRS with HUA in total population, non-elderly and elderly
| NGRS组合 | 总体人群 | 非老年人 | 老年人 | |||
|---|---|---|---|---|---|---|
| AUC(95%CI) | P值 | AUC(95%CI) | P值 | AUC(95%CI) | P值 | |
| HUANGRS3 | 0.76(0.61~0.82) | <0.001 | 0.72(0.59~0.81) | <0.001 | 0.79(0.66~0.86) | <0.001 |
| HUANGRS4 | 0.68(0.56~0.75) | <0.001 | 0.78(0.63~0.83) | 0.001 | 0.82(0.74~0.88) | <0.001 |
| HUANGRS5 | 0.82(0.73~0.87) | <0.001 | 0.81(0.73~0.87) | <0.001 | 0.77(0.63~0.83) | <0.001 |
| HUANGRS6 | 0.67(0.53~0.73) | <0.001 | 0.75(0.61~0.81) | 0.001 | 0.79(0.64~0.85) | 0.001 |
| 人群 | 预测因子 | Logistic回归方程 | AUC预测效力检验 | ||
|---|---|---|---|---|---|
| OR(95%CI) | P值 | AUC(95%CI) | P值 | ||
| 总人群 | HUANGRS5 | 1.39(1.17~2.16) | 0.005 | 0.82(0.73~0.87) | <0.001 |
| HUANGRS5+ | 1.43(1.25~2.22) | 0.002 | 0.90(0.79~1.28) | 0.002 | |
| 非老年人 | HUANGRS5 | 1.44(1.19~2.26) | 0.006 | 0.81(0.73~0.87) | <0.001 |
| HUANGRS5+ | 1.52(1.22~4.31) | 0.001 | 0.89(0.77~1.24) | 0.001 | |
| 老年人 | HUANGRS4 | 1.66(1.36~4.97) | 0.007 | 0.82(0.74~0.88) | <0.001 |
| HUANGRS4+ | 1.68(1.37~5.00) | 0.001 | 0.88(0.77~1.18) | <0.001 | |
Table 9 Logistic regression analysis and prediction effectiveness comparison of prediction models with NGRS added to normal values
| 人群 | 预测因子 | Logistic回归方程 | AUC预测效力检验 | ||
|---|---|---|---|---|---|
| OR(95%CI) | P值 | AUC(95%CI) | P值 | ||
| 总人群 | HUANGRS5 | 1.39(1.17~2.16) | 0.005 | 0.82(0.73~0.87) | <0.001 |
| HUANGRS5+ | 1.43(1.25~2.22) | 0.002 | 0.90(0.79~1.28) | 0.002 | |
| 非老年人 | HUANGRS5 | 1.44(1.19~2.26) | 0.006 | 0.81(0.73~0.87) | <0.001 |
| HUANGRS5+ | 1.52(1.22~4.31) | 0.001 | 0.89(0.77~1.24) | 0.001 | |
| 老年人 | HUANGRS4 | 1.66(1.36~4.97) | 0.007 | 0.82(0.74~0.88) | <0.001 |
| HUANGRS4+ | 1.68(1.37~5.00) | 0.001 | 0.88(0.77~1.18) | <0.001 | |
| 人群 | 预测因素 | β | SE | χ2值 | OR | 95%CI | P值 |
|---|---|---|---|---|---|---|---|
| 总人群 | HUANGRS5 | 2.328 | 0.173 | 12.068 | 4.112 | 1.45~8.87 | 0.002 |
| HUANGRS5+ | 1.517 | 0.165 | 23.113 | 3.428 | 1.25~7.66 | 0.003 | |
| 非老年人 | HUANGRS5 | 3.143 | 0.521 | 5.625 | 5.614 | 2.72~11.21 | <0.001 |
| HUANGRS5+ | 2.325 | 0.443 | 2.877 | 4.522 | 1.52~8.95 | 0.002 | |
| 老年人 | HUANGRS4 | 1.215 | 0.387 | 11.142 | 3.245 | 1.11~6.96 | <0.001 |
| HUANGRS4+ | 1.314 | 0.402 | 7.512 | 4.357 | 1.63~8.95 | 0.002 |
Table 10 Multilevel Logistic regression analysis of the influence of hyperuricemia population multi-factor
| 人群 | 预测因素 | β | SE | χ2值 | OR | 95%CI | P值 |
|---|---|---|---|---|---|---|---|
| 总人群 | HUANGRS5 | 2.328 | 0.173 | 12.068 | 4.112 | 1.45~8.87 | 0.002 |
| HUANGRS5+ | 1.517 | 0.165 | 23.113 | 3.428 | 1.25~7.66 | 0.003 | |
| 非老年人 | HUANGRS5 | 3.143 | 0.521 | 5.625 | 5.614 | 2.72~11.21 | <0.001 |
| HUANGRS5+ | 2.325 | 0.443 | 2.877 | 4.522 | 1.52~8.95 | 0.002 | |
| 老年人 | HUANGRS4 | 1.215 | 0.387 | 11.142 | 3.245 | 1.11~6.96 | <0.001 |
| HUANGRS4+ | 1.314 | 0.402 | 7.512 | 4.357 | 1.63~8.95 | 0.002 |
| 人群 | 预测因素 | 风险预测模型 |
|---|---|---|
| 非老年人 | HUANGRS5+ | Logist P=-1.206+2.132×(0.959X1+1.441X3+2.383X4+2.892X5+1.521X6+1.384X7) |
| 老年人 | HUANGRS4+ | Logist P=-3.102+2.114×(0.959X1+1.441X3+2.383X4+2.892X5+1.384X7) |
Table 11 HUA population non-genetic risk prediction model
| 人群 | 预测因素 | 风险预测模型 |
|---|---|---|
| 非老年人 | HUANGRS5+ | Logist P=-1.206+2.132×(0.959X1+1.441X3+2.383X4+2.892X5+1.521X6+1.384X7) |
| 老年人 | HUANGRS4+ | Logist P=-3.102+2.114×(0.959X1+1.441X3+2.383X4+2.892X5+1.384X7) |
| 指标 | AUC | 95%CI | 灵敏度(%) | 特异度(%) | 最佳截断值 | P值 |
|---|---|---|---|---|---|---|
| 非老年人HUANGRS5+ | 0.89 | 0.77~1.24 | 89.5 | 78.6 | 1.503 | 0.001 |
| 老年人HUANGRS4+ | 0.88 | 0.77~1.18 | 92.1 | 77.8 | 1.427 | 0.001 |
Table 12 Prediction effectiveness comparison of HUA risk prediction model
| 指标 | AUC | 95%CI | 灵敏度(%) | 特异度(%) | 最佳截断值 | P值 |
|---|---|---|---|---|---|---|
| 非老年人HUANGRS5+ | 0.89 | 0.77~1.24 | 89.5 | 78.6 | 1.503 | 0.001 |
| 老年人HUANGRS4+ | 0.88 | 0.77~1.18 | 92.1 | 77.8 | 1.427 | 0.001 |
| 人群 | 预测因子 | 验证AUC(95%CI) | 模型AUC(95%CI) | P值 |
|---|---|---|---|---|
| 非老年人 | HUANGRS5+ | 0.88(0.77~1.22) | 0.89(0.77~1.24) | 0.008 |
| 老年人 | HUANGRS4+ | 0.87(0.76~1.16) | 0.88(0.77~1.18) | 0.012 |
Table 13 HUA comparison of prediction effectiveness of risk prediction models
| 人群 | 预测因子 | 验证AUC(95%CI) | 模型AUC(95%CI) | P值 |
|---|---|---|---|---|
| 非老年人 | HUANGRS5+ | 0.88(0.77~1.22) | 0.89(0.77~1.24) | 0.008 |
| 老年人 | HUANGRS4+ | 0.87(0.76~1.16) | 0.88(0.77~1.18) | 0.012 |
| 人群 | 预测值(%) | ||||
|---|---|---|---|---|---|
| 非老年人 | ≤18a | 18~29b | 29~34c | 34~40d | >40e |
| 老年人 | ≤14a | 14~26b | 26~31c | 31~36d | >36e |
Table 14 Comparison table of predicted and risk level of HUA in non-elderly and elderly
| 人群 | 预测值(%) | ||||
|---|---|---|---|---|---|
| 非老年人 | ≤18a | 18~29b | 29~34c | 34~40d | >40e |
| 老年人 | ≤14a | 14~26b | 26~31c | 31~36d | >36e |
| [1] |
彭成,袁丙坤,伍成凯,等. 广州市6991名企业职工饮用不同饮品发生高尿酸血症风险的研究[J]. 护理学报, 2023, 30(12): 17-21. DOI: 10.16460/j.issn1008-9969.2023.12.017.
|
| [2] |
温少诗,王涛. 补肾中药对于高尿酸血症治疗作用研究[J]. 辽宁中医药大学学报, 2018, 20(10): 89-91.
|
| [3] |
|
| [4] |
中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志, 2020, 36(1): 1-13.
|
| [5] |
沈小芳,张萍,罗瑞琼. 广西地区2型糖尿病患者高尿酸血症流行状况及危险因素分析[J]. 医学信息, 2023, 36(9): 54-57, 66.
|
| [6] |
中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 痛风及高尿酸血症基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2020, 19(4): 293-303.
|
| [7] |
刘宇婷,孙维峰. 高尿酸血症患者血清脂联素、单核细胞趋化蛋白1水平变化及意义[J]. 山东医药, 2017, 57(21): 5-8.
|
| [8] |
于晓丽. 老年脑卒中患者居家健康管理模型的构建研究[D]. 苏州: 苏州大学, 2021.
|
| [9] |
徐霞,胡元会,宋庆桥,等. 两种公式估算的肾小球滤过率对慢性心力衰竭患者远期预后预测价值比较研究[J]. 中国循证心血管医学杂志, 2022, 14(5): 554-558.
|
| [10] |
|
| [11] |
庄红玲,张程亮,桂玲,等. 1例宫颈癌患者合并肾功能不全和高尿酸血症的药物治疗分析[J]. 中国药师, 2017, 20(6): 1092-1094. DOI: 10.3969/j.issn.1008-049X.2017.06.035.
|
| [12] |
杨进平,闻瑛,周海燕,等. 补阳还五汤辅治脑梗死恢复期临床观察[J]. 实用中医药杂志, 2021, 37(12): 2034-2035.
|
| [13] |
高华,戈吉祥,杨锐英,等. 代谢综合征患者静息心率与靶器官损害的相关性分析研究[J]. 实用心脑肺血管病杂志, 2010, 18(12): 1755-1759.
|
| [14] |
中国肥胖问题工作组. 中国成人超重与肥胖症预防与控制指南(节录)[J]. 营养学报, 2004, 26(1): 1-4. DOI: 10.3321/j.issn:0512-7955.2004.01.001.
|
| [15] |
李杰. GDF-15对冠状动脉搭桥围术期心力衰竭的诊断与预测价值[D]. 天津: 天津医科大学, 2017.
|
| [16] |
李海英. 中性粒细胞明胶酶相关脂质运载蛋白与狼疮性肾炎活动性及病理分型关系的初步研究[D]. 长沙: 中南大学, 2014.
|
| [17] |
陈莹,杨彩哲,王良宸,等. 趾臂指数对糖尿病足患者心脑血管事件发生风险的预测价值研究[J]. 中国全科医学, 2020, 23(34): 4332-4336, 4348. DOI: 10.12114/j.issn.1007-9572.2020.00.313.
|
| [18] |
张经纬. 儿童急性淋巴细胞性白血病环境危险因素研究[D]. 天津: 天津医科大学, 2017.
|
| [19] |
桂李暄. 遗传风险评分预测中国汉族人群冠心病患病风险[D]. 武汉: 华中科技大学, 2014.
|
| [20] |
蒋曦依,李璐,唐慧娟,等. 结直肠癌高危人群多因素风险预测模型及评价[J]. 浙江大学学报(医学版), 2018, 47(2): 194-200.
|
| [21] |
|
| [22] |
唐小芬,仇小强,曾小云,等. 广西35~74岁壮族居民高尿酸血症患病情况及其影响因素分析[J]. 广西医科大学学报, 2021, 38(3): 583-590. DOI: 10.16190/j.cnki.45-1211/r.2021.03.028.
|
| [23] |
胡浩杰,宋晓昀,金东辉,等. 中国四省18岁及以上成年居民肥胖与高尿酸血症的关联[J]. 环境与职业医学, 2021, 38(9): 1015-1021. DOI: 10.13213/j.cnki.jeom.2021.21015.
|
| [24] |
李禄伟,黄倩,施佳成,等. 超重及肥胖人群高尿酸血症发病风险预测模型的构建及评价[J]. 实用医学杂志, 2021, 37(18): 2401-2406. DOI: 10.3969/j.issn.1006-5725.2021.18.019.
|
| [25] |
|
| [26] |
马利丹,孙瑞霞,辛颖,等. 不同体重指数痛风患者临床特点分析[J]. 中华内科杂志, 2017, 56(5): 353-357.
|
| [27] |
|
| [28] |
|
| [29] |
陈蕾,伍成凯,康峻鸣,等. 我国45岁及以上中老年人群高尿酸血症与常见慢性病的关联研究[J]. 中国全科医学, 2021, 24(4): 447-452. DOI: 10.12114/j.issn.1007-9572.2020.00.599.
|
| [30] |
尹相林,魏金枫,姚嵩坡,等. 油田职业老年男性人群肥胖指标与高尿酸血症相关性[J]. 中国老年学杂志, 2022, 42(16): 3913-3916. DOI: 10.3969/j.issn.1005-9202.2022.16.011.
|
| [31] |
孙茹茹,沈捷. 多囊卵巢综合征与高尿酸血症的关系[J]. 自然科学, 2017(2): 113-119.
|
| [32] |
宋华,赵莉,宋艳玲. 中老年人高血糖高血脂发生高尿酸血症的危险因素研究[J]. 系统医学, 2022, 7(19): 99-102.
|
| [33] |
张文,李楠,刘守东,等. 海勤疗养员高尿酸血症对高血脂及肝功能的影响[J]. 中国疗养医学, 2020, 29(12): 1259-1261.
|
| [34] |
丁贤彬,毛德强,沈卓之,等. 重庆市城市与农村居民慢性病相关行为与生活方式比较[J]. 中国慢性病预防与控制, 2015, 23(7): 512-515. DOI: 10.16386/j.cjpccd.issn.1004-6194.2015.07.009.
|
| [35] |
杨朵儿,汤少梁. 基于Tobit模型的川冀甘三省慢性病患者健康相关生命质量影响因素研究[J]. 中国全科医学, 2018, 21(28): 3459-3466, 3470. DOI: 10.12114/j.issn.1007-9572.2018.28.010.
|
| [36] |
王晶,陈长香,李淑杏,等. 河北省老年人婚姻状况与生存质量的相关性[J]. 中国老年学杂志, 2015, 35(9): 2522-2523.
|
| [37] |
李剑,袁泉,吴清锋,等. 赣南地区高尿酸血症相关性研究[J]. 赣南医学院学报, 2022, 42(8): 852-856.
|
| [38] |
何伟林. 中国队列人群高胆固醇血症发病率及其影响因素[D]. 北京: 北京协和医学院, 2018.
|
| [39] |
|
| [40] |
宋小玲,蒋芝月,葛雯,等. 高尿酸血症患病风险预测模型的构建[J]. 中国初级卫生保健, 2022, 36(10): 51-54.
|
| [41] |
于汉成,张霁娟,刘峰,等. 基于纵向健康体检数据的高尿酸血症发病风险预测模型[J]. 现代预防医学, 2021, 48(23): 4408-4412.
|
| [42] |
彭成. 高尿酸血症发病风险预测模型研究[D]. 广州: 南方医科大学, 2023.
|
| [43] |
陈京蓉,罗书全,熊鹰,等. 基于回归和分类树模型的重庆7~17岁儿童青少年高尿酸血症影响因素分析[J]. 中国食品卫生杂志, 2022, 34(5): 1077-1082. DOI: 10.13590/j.cjfh.2022.05.034.
|
| [44] |
肖宁婷,李莉,郭雪梅,等. 儿童青少年高尿酸血症风险预测模型的构建与验证[J]. 护理研究, 2024, 38(11): 1908-1913.
|
| [45] |
|
| [46] |
杨兴华,陶秋山,詹思延,等. 中国台湾35~74岁健检人群高尿酸血症5年发病风险预测模型[J]. 中国预防医学杂志, 2013, 14(9): 655-659. DOI: 10.16506/j.1009-6639.2013.09.016.
|
| [47] |
李金金. 天津市慢性病队列研究及风险预测模型的建立[D]. 天津: 天津医科大学, 2018.
|
| [1] | LIU Xiang, CHEN Hong, CUI Rui, GUO Zhichao, LI Panpan, CAO Zilong, JI Yiqing, YU Wenya. Consistencies and Differences in Early Childhood Development Characteristics in Megacities: a Retrospective Cohort Study [J]. Chinese General Practice, 2026, 29(11): 1411-1421. |
| [2] | LI Qiuchun, SU Ping, PANG Jinhong, CHEN Qiaoqiao, ZHAO Yingying, HE Ruiyan, WANG Yue, CHEN Xueyu, QIAO Junpeng, CHI Weiwei. Association of Triglyceride Glucose Index with Cardiovascular Disease in Cardiovascular-Kidney-Metabolic Syndrome Stage 0-3 Population: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(09): 1129-1136. |
| [3] | ZHANG Ziyu, HAN Shukui, MA Xin, SONG Panpan, MA Jinxiang, REN Yitao, CHEN Hongru. The Disease Burden of Drug Use Disorders in the Chinese Population from 1990 to 2021 and Trend Predictions from 2022 to 2046 [J]. Chinese General Practice, 2026, 29(08): 1069-1076. |
| [4] | ZHAO Qianqian, ZHANG Mei, LI Yanying, ZHANG Yanhong, YAN Wenhua, PAN Hui, BAN Bo. Clinical Characteristics of Growth Hormone Deficiency and Analysis of the Efficacy of Recombinant Human Growth Hormone: a Ten-year Longitudinal Cohort Study [J]. Chinese General Practice, 2026, 29(06): 733-740. |
| [5] | LEI Yingying, ZHENG Siying, WANG Wenxin, JIANG Hong. Prevalence Trend and Prediction of Hypertensive Heart Disease in the World and China from 1990 to 2021 [J]. Chinese General Practice, 2026, 29(05): 641-648. |
| [6] | ZHU Chenrui, LI Na, WU Yuntao, ZHAO Haiyan, HUANG Zhe, LIU Yan, JI Chunpeng, WU Shouling. The Impact of Serum Uric Acid Levels on New-onset Atrioventricular Block: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(05): 583-590. |
| [7] | JIANG Xiaorui, YAN Yuyao, WEI Jingjing, QIAO Lijie, PENG Guangcao, ZHU Mingjun. Systematic Review of Risk Prediction Models for Concurrent Heart Failure with Coronary Heart Disease [J]. Chinese General Practice, 2026, 29(03): 393-402. |
| [8] | LU Yanqiu, WU Yuntao, LIU Shaopeng, LIN Haiying, DENG Huiyou, WU Ying, HUANG Zhe, YANG Peng, WU Shouling, LI Yun. Effect of Blood Pressure Trajectory on Cardiovascular Disease in Population with High-normal Blood Pressure: a Study Based on the Kailuan Cohort [J]. Chinese General Practice, 2026, 29(03): 299-310. |
| [9] | DIJI Zhuoma, ZOU Yanqiu, ZHENG Dixin, HU Mengjie, LIU Xiaoxue, JIANG Xia, FAN Mengyu, LI Jiayuan. Association of Social Isolation, Loneliness, with Incidence Risk of Cardiovascular Diseases: a Prospective Chinese Study [J]. Chinese General Practice, 2026, 29(01): 122-128. |
| [10] | ZHANG Shu, CHENG Yu, WU Shouling, CHEN Shuohua, WU Yuntao. The Impact of Cumulative Plasma Atherogenic Index Exposure on Incident Cardiovascular Disease in Non-Diabetic Individuals: a Cohort Study [J]. Chinese General Practice, 2025, 28(36): 4558-4565. |
| [11] | LIU Ruiyue, YANG Xuemei, ZHAO Naihui, WEN Xinran, CAI Xi, LIANG Yajing, MA Jiajia, WU Shouling, CUI Liufu. The Impact of the Ratio of High-sensitivity C-reactive Protein to Albumin on Incident Cardiovascular Disease in Different Age Groups: a Cohort Study [J]. Chinese General Practice, 2025, 28(36): 4566-4577. |
| [12] | ZENG Minghui, KUAI Wentao, CHEN Lin, HAN Jiaxin, XU Lianxin, GE Liying, DAI Rongrong, MI Yuqiang, XU Liang. Effect of Type 2 Diabetes Mellitus on the Efficacy of Nucleoside (Acid) Analogues in the Treatment of Chronic Hepatitis B [J]. Chinese General Practice, 2025, 28(35): 4414-4420. |
| [13] | XIANG Fengling, WANG Yuankun, WANG Xiaoyan, HE Shengjie, GAN Jinhua. The Prevalence of Hyperuricemia among Children and Adolescents in China: a Meta-analysis [J]. Chinese General Practice, 2025, 28(33): 4206-4213. |
| [14] | WANG Biyou, GAO Ying, YOU Junfang, LIU Li, ZHANG Qing, SU Haiyan. Canonical Correlation Analysis of Lipid Ratios and Inflammatory Markers in Individuals at Risk of Cardiovascular Disease [J]. Chinese General Practice, 2025, 28(33): 4132-4139. |
| [15] | ZHANG Yongqing, LI Na, GAO Yili, QIN Jiawen, YU Haiping, SHI Hui. Analysis on the Trend of Disease Burden of Hearing Loss in Middle-aged and Elderly People in China from 1990 to 2021 [J]. Chinese General Practice, 2025, 28(33): 4227-4233. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||